PropertyEU

Oxford Biomedica completes €68m sale & leaseback of Windrush Court

By Branislav Pekic 2022-11-14T00:00:00

Oxford Biomedica

UK-based gene and cell therapy group Oxford Biomedica has sold its Windrush Court facility in Oxford to Kadans Science Partner for £60 mln (€68 mln).

You have now reached your article limit

Already have an IPE Real Assets account? Sign in

PropertyEU has merged with IPE Real Assets

If you had a PropertyEU account, simply reset your password to get access to IPE Real Assets.

New users can Register for free today for access to the PropertyEU Archive and IPE Real Assets.

Register today

Registration also includes access to IPE

Gated access promo

Five reasons to register today

  1. Access IPE Real Assets articles
  2. Daily news alerts and updates
  3. Track what the world’s leading institutional investors are doing
  4. Learn about the latest industry research and market analysis
  5. Comprehensive archive of data and intelligence on investors and fund managers, including the PropertyEU Archive
SEE HOW IPE REAL ASSETS CAN HELP YOUR business